Skip to main content

Help may be on the way, via this Malvern biopharm firm, for male/female pattern baldness

The Chester County company posted positive results from a mid-stage clinical trial of its new drug candidate for a condition that affects an estimated 80 million adults in the United States.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.